oncoletterweb.oncoletter.ch/files/cto_layout/Kongressdateien/ASH... · 2015. 12. 8. · Randomized,...

21

Transcript of oncoletterweb.oncoletter.ch/files/cto_layout/Kongressdateien/ASH... · 2015. 12. 8. · Randomized,...

Page 1: oncoletterweb.oncoletter.ch/files/cto_layout/Kongressdateien/ASH... · 2015. 12. 8. · Randomized, double-blind, placebo-controlled study in adult ß-thalasserupatients (including
Page 2: oncoletterweb.oncoletter.ch/files/cto_layout/Kongressdateien/ASH... · 2015. 12. 8. · Randomized, double-blind, placebo-controlled study in adult ß-thalasserupatients (including
Page 3: oncoletterweb.oncoletter.ch/files/cto_layout/Kongressdateien/ASH... · 2015. 12. 8. · Randomized, double-blind, placebo-controlled study in adult ß-thalasserupatients (including
Page 4: oncoletterweb.oncoletter.ch/files/cto_layout/Kongressdateien/ASH... · 2015. 12. 8. · Randomized, double-blind, placebo-controlled study in adult ß-thalasserupatients (including
Page 5: oncoletterweb.oncoletter.ch/files/cto_layout/Kongressdateien/ASH... · 2015. 12. 8. · Randomized, double-blind, placebo-controlled study in adult ß-thalasserupatients (including
Page 6: oncoletterweb.oncoletter.ch/files/cto_layout/Kongressdateien/ASH... · 2015. 12. 8. · Randomized, double-blind, placebo-controlled study in adult ß-thalasserupatients (including
Page 7: oncoletterweb.oncoletter.ch/files/cto_layout/Kongressdateien/ASH... · 2015. 12. 8. · Randomized, double-blind, placebo-controlled study in adult ß-thalasserupatients (including
Page 8: oncoletterweb.oncoletter.ch/files/cto_layout/Kongressdateien/ASH... · 2015. 12. 8. · Randomized, double-blind, placebo-controlled study in adult ß-thalasserupatients (including
Page 9: oncoletterweb.oncoletter.ch/files/cto_layout/Kongressdateien/ASH... · 2015. 12. 8. · Randomized, double-blind, placebo-controlled study in adult ß-thalasserupatients (including
Page 10: oncoletterweb.oncoletter.ch/files/cto_layout/Kongressdateien/ASH... · 2015. 12. 8. · Randomized, double-blind, placebo-controlled study in adult ß-thalasserupatients (including
Page 11: oncoletterweb.oncoletter.ch/files/cto_layout/Kongressdateien/ASH... · 2015. 12. 8. · Randomized, double-blind, placebo-controlled study in adult ß-thalasserupatients (including
Page 12: oncoletterweb.oncoletter.ch/files/cto_layout/Kongressdateien/ASH... · 2015. 12. 8. · Randomized, double-blind, placebo-controlled study in adult ß-thalasserupatients (including
Page 13: oncoletterweb.oncoletter.ch/files/cto_layout/Kongressdateien/ASH... · 2015. 12. 8. · Randomized, double-blind, placebo-controlled study in adult ß-thalasserupatients (including
Page 14: oncoletterweb.oncoletter.ch/files/cto_layout/Kongressdateien/ASH... · 2015. 12. 8. · Randomized, double-blind, placebo-controlled study in adult ß-thalasserupatients (including
Page 15: oncoletterweb.oncoletter.ch/files/cto_layout/Kongressdateien/ASH... · 2015. 12. 8. · Randomized, double-blind, placebo-controlled study in adult ß-thalasserupatients (including
Page 16: oncoletterweb.oncoletter.ch/files/cto_layout/Kongressdateien/ASH... · 2015. 12. 8. · Randomized, double-blind, placebo-controlled study in adult ß-thalasserupatients (including
Page 17: oncoletterweb.oncoletter.ch/files/cto_layout/Kongressdateien/ASH... · 2015. 12. 8. · Randomized, double-blind, placebo-controlled study in adult ß-thalasserupatients (including
Page 18: oncoletterweb.oncoletter.ch/files/cto_layout/Kongressdateien/ASH... · 2015. 12. 8. · Randomized, double-blind, placebo-controlled study in adult ß-thalasserupatients (including
Page 19: oncoletterweb.oncoletter.ch/files/cto_layout/Kongressdateien/ASH... · 2015. 12. 8. · Randomized, double-blind, placebo-controlled study in adult ß-thalasserupatients (including
Page 20: oncoletterweb.oncoletter.ch/files/cto_layout/Kongressdateien/ASH... · 2015. 12. 8. · Randomized, double-blind, placebo-controlled study in adult ß-thalasserupatients (including
Page 21: oncoletterweb.oncoletter.ch/files/cto_layout/Kongressdateien/ASH... · 2015. 12. 8. · Randomized, double-blind, placebo-controlled study in adult ß-thalasserupatients (including

web.oncoletter.chweb.oncoletter.ch/files/cto_layout/Kongressdateien/MWS... ·  · 2015-09-24Common Themes Does patient need treatment If yes, are they fit or frail (2 drugs) Should

web.oncoletter.chweb.oncoletter.ch/files/cto_layout/Kongressdateien/MWS... ·  · 2015-09-24Common Themes Does patient need treatment If yes, are they fit or frail (2 drugs) Should

Slide 2 / 23 - web.oncoletter.chweb.oncoletter.ch/files/cto_layout/Kongressdateien/SABCS2015/S4-0… · slide 1 / 23 slide 2 / 23 page 1. undefined s4-04 lobular carcinoma in situ

Slide 2 / 23 - web.oncoletter.chweb.oncoletter.ch/files/cto_layout/Kongressdateien/SABCS2015/S4-0… · slide 1 / 23 slide 2 / 23 page 1. undefined s4-04 lobular carcinoma in situ

OPERATING WEIGHT ENGINE OUTPUT SHOVEL CAPACITY …ar250.de/files/cto_layout/content/prospekt_ar250_en.pdf · STANDARD SHOVEL CAPACITY 13,800 2.4 160 FIRST IMPRESSIONS COUNT! We think

OPERATING WEIGHT ENGINE OUTPUT SHOVEL CAPACITY …ar250.de/files/cto_layout/content/prospekt_ar250_en.pdf · STANDARD SHOVEL CAPACITY 13,800 2.4 160 FIRST IMPRESSIONS COUNT! We think

SABCS 2016web.oncoletter.ch/files/cto_layout/Kongressdateien/SABCS2016/SLID… · Double-blind Concordance Study of Breast Cancer Recommendations Between Manipal Multidisc* Tumor

SABCS 2016web.oncoletter.ch/files/cto_layout/Kongressdateien/SABCS2016/SLID… · Double-blind Concordance Study of Breast Cancer Recommendations Between Manipal Multidisc* Tumor

web.oncoletter.chweb.oncoletter.ch/files/cto_layout/Kongressdateien/ASH2014/ASH2014_80.pdf · Tx to at least one prior regumen and then developed PO s 60 days corn*tTtg their last

web.oncoletter.chweb.oncoletter.ch/files/cto_layout/Kongressdateien/ASH2014/ASH2014_80.pdf · Tx to at least one prior regumen and then developed PO s 60 days corn*tTtg their last

oncoletterweb.oncoletter.ch/files/cto_layout/Kongressdateien/... · National reference labs Central sample collection Marker identification (IGH, t(11;14)) Sequencing and ASO Primer

oncoletterweb.oncoletter.ch/files/cto_layout/Kongressdateien/... · National reference labs Central sample collection Marker identification (IGH, t(11;14)) Sequencing and ASO Primer

Slide 2 / 28web.oncoletter.ch/files/cto_layout/Kongressdateien/SABCS2015/S6-0… · slide 1 / 28 slide 2 / 28 page 1. undefined s6-04 patient-reported outcome (pro) results, nrg oncology/nsabp

Slide 2 / 28web.oncoletter.ch/files/cto_layout/Kongressdateien/SABCS2015/S6-0… · slide 1 / 28 slide 2 / 28 page 1. undefined s6-04 patient-reported outcome (pro) results, nrg oncology/nsabp

Intramedullary Nailing Intramed System Interlocking System ...1.treu.com/portfolio-details/nails.html?file=files/cto_layout/download… · Intramedullary Nailing Intramed System Interlocking

Intramedullary Nailing Intramed System Interlocking System ...1.treu.com/portfolio-details/nails.html?file=files/cto_layout/download… · Intramedullary Nailing Intramed System Interlocking

Plaster Shears and Instruments - 1.treu.com1.treu.com/portfolio-details/plaster.html?file=files/cto_layout/downloads/10 - Plaster... · Säge lassen sich alle Gips- und Kunststoffverbände

Plaster Shears and Instruments - 1.treu.com1.treu.com/portfolio-details/plaster.html?file=files/cto_layout/downloads/10 - Plaster... · Säge lassen sich alle Gips- und Kunststoffverbände

SELECTED REFERENCES OF TRAFOTEK DELIVERIES SELECTED ...cis-ship.com/files/cto_layout/downloads/References 1 March 2016.pdf · SELECTED REFERENCES OF TRAFOTEK DELIVERIES SELECTED REFERENCES

SELECTED REFERENCES OF TRAFOTEK DELIVERIES SELECTED ...cis-ship.com/files/cto_layout/downloads/References 1 March 2016.pdf · SELECTED REFERENCES OF TRAFOTEK DELIVERIES SELECTED REFERENCES

DSC 5266 - Willkommen bei oncoletter - Oncoletter, …web.oncoletter.ch/files/cto_layout/Kongressdateien/ASC… ·  · 2014-01-18Metastatic Gastric or Gastroesophageal Junction (GEJ)

DSC 5266 - Willkommen bei oncoletter - Oncoletter, …web.oncoletter.ch/files/cto_layout/Kongressdateien/ASC… ·  · 2014-01-18Metastatic Gastric or Gastroesophageal Junction (GEJ)

Slide 2 / 17web.oncoletter.ch/files/cto_layout/Kongressdateien/SABCS2015/S5-0… · slide 9 / 17 slide 10 / 17 page 5. undefined s5-05 trastuzumab emtansine improves overall survival

Slide 2 / 17web.oncoletter.ch/files/cto_layout/Kongressdateien/SABCS2015/S5-0… · slide 9 / 17 slide 10 / 17 page 5. undefined s5-05 trastuzumab emtansine improves overall survival

web.oncoletter.chweb.oncoletter.ch/files/cto_layout/Kongressdateien/MWS2015/Larocca.pdf · MYELOMA WORKSHOP Rome. Auditorium Parco della Musica September 23-26, 2015 Geriatric assessment

web.oncoletter.chweb.oncoletter.ch/files/cto_layout/Kongressdateien/MWS2015/Larocca.pdf · MYELOMA WORKSHOP Rome. Auditorium Parco della Musica September 23-26, 2015 Geriatric assessment

Folie001 - oncoletterweb.oncoletter.ch/files/cto_layout/Kongressdateien/STGALLEN/2... · Characterization of primary tumors Beckman-Coulter Brahms Diapat/Mosaiques DiaSorin Epigenomics

Folie001 - oncoletterweb.oncoletter.ch/files/cto_layout/Kongressdateien/STGALLEN/2... · Characterization of primary tumors Beckman-Coulter Brahms Diapat/Mosaiques DiaSorin Epigenomics

Thema: Willensvollstreckung Referenten: Dr. Markus Pichler ...szlaw.ch/files/cto_layout/pdf_referate/referate... · Mietverträge, Inkasso, Instandhaltung der Liegenschaften, Wahrnehmung

Thema: Willensvollstreckung Referenten: Dr. Markus Pichler ...szlaw.ch/files/cto_layout/pdf_referate/referate... · Mietverträge, Inkasso, Instandhaltung der Liegenschaften, Wahrnehmung

Slide 2 / 20 - oncoletterweb.oncoletter.ch/files/cto_layout/Kongressdateien/SABCS2015/S5-07.… · NEGATIVE ADVANCED BREAST CANCER ENROLLED IN KEYNOTE-028 Speaker: Hope S Rugo Slide

Slide 2 / 20 - oncoletterweb.oncoletter.ch/files/cto_layout/Kongressdateien/SABCS2015/S5-07.… · NEGATIVE ADVANCED BREAST CANCER ENROLLED IN KEYNOTE-028 Speaker: Hope S Rugo Slide

Workshop 11 November 2019 - icond.deicond.de/start.html?file=files/cto_layout/img/icond/download/2019/...gress“. Please find further information about the venue on 2019 wird die

Workshop 11 November 2019 - icond.deicond.de/start.html?file=files/cto_layout/img/icond/download/2019/...gress“. Please find further information about the venue on 2019 wird die

Pretreatment with Prasugrel in Non ST-Segment Elevation ...web.oncoletter.ch/files/cto_layout/Kongressdateien/ECCO ESMO 201… · sponsored by Daiichi Sankyo and Eli Lilly, and was

Pretreatment with Prasugrel in Non ST-Segment Elevation ...web.oncoletter.ch/files/cto_layout/Kongressdateien/ECCO ESMO 201… · sponsored by Daiichi Sankyo and Eli Lilly, and was

SABCS 2013 - oncoletterweb.oncoletter.ch/files/cto_layout/Kongressdateien/... · 'One P30+DOC randomized patient received RAM DOC n Cycle I only therefore is included in the RAM DOC

SABCS 2013 - oncoletterweb.oncoletter.ch/files/cto_layout/Kongressdateien/... · 'One P30+DOC randomized patient received RAM DOC n Cycle I only therefore is included in the RAM DOC

SABCS 2016 - oncoletterweb.oncoletter.ch/files/cto_layout/Kongressdateien/SABCS2016/SLID… · -2016 DEC. 6-10 SAN ANTONIO BREAST CANCER SYMPOSIUM Financial disclosure: Consultancy

SABCS 2016 - oncoletterweb.oncoletter.ch/files/cto_layout/Kongressdateien/SABCS2016/SLID… · -2016 DEC. 6-10 SAN ANTONIO BREAST CANCER SYMPOSIUM Financial disclosure: Consultancy